Warby Parker Inc. (WRBY) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
233 SPRING STREET NEW YORK, NY 10013 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3851 - Ophthalmic Goods (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 254,161 | 216,894 | 208,585 | 256,416 | |||
| Cash and cash equivalent | 254,161 | 216,894 | 208,585 | 256,416 | |||
| Receivables | 1,948 | 1,779 | 1,435 | 992 | |||
| Inventory, net of allowances, customer advances and progress billings | 52,345 | 62,234 | 68,848 | 57,095 | |||
| Inventory | 52,345 | 62,234 | 68,848 | 57,095 | |||
| Other undisclosed current assets | 17,592 | 17,712 | 15,700 | 13,477 | |||
| Total current assets: | 326,046 | 298,619 | 294,568 | 327,980 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 171,284 | 122,305 | 127,014 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 170,464 | 152,332 | 138,628 | 112,195 | |||
| Other noncurrent assets | 8,696 | 7,056 | 8,497 | 471 | |||
| Total noncurrent assets: | 350,444 | 281,693 | 274,139 | 112,666 | |||
| TOTAL ASSETS: | 676,490 | 580,312 | 568,707 | 440,646 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 75,128 | 68,776 | 79,013 | 91,730 | |||
| Accounts payable | 23,519 | 22,456 | 20,791 | 30,890 | |||
| Accrued liabilities | 51,609 | 46,320 | 58,222 | 60,840 | |||
| Deferred revenue | 32,358 | 31,617 | 25,628 | 22,073 | |||
| Other liabilities | 2,633 | 2,411 | 2,370 | 4,301 | |||
| Other undisclosed current liabilities | 20,235 | 24,286 | 22,546 | ||||
| Total current liabilities: | 130,354 | 127,090 | 129,557 | 118,104 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 206,063 | 151,435 | 152,504 | 36,544 | |||
| Deferred rent credit | 36,544 | ||||||
| Other liabilities | 943 | 1,264 | 1,672 | ||||
| Operating lease, liability | 205,120 | 150,171 | 150,832 | ||||
| Total noncurrent liabilities: | 206,063 | 151,435 | 152,504 | 36,544 | |||
| Total liabilities: | 336,417 | 278,525 | 282,061 | 154,648 | |||
| Equity | |||||||
| Equity, attributable to parent, including: | 340,073 | 301,787 | 286,646 | 285,998 | |||
| Additional paid in capital | 1,029,220 | 970,135 | 890,915 | 779,212 | |||
| Accumulated other comprehensive income (loss) | (1,938) | (1,529) | (647) | 16 | |||
| Accumulated deficit | (687,221) | (666,831) | (603,634) | (493,241) | |||
| Other undisclosed equity, attributable to parent | 12 | 12 | 12 | 11 | |||
| Total equity: | 340,073 | 301,787 | 286,646 | 285,998 | |||
| TOTAL LIABILITIES AND EQUITY: | 676,490 | 580,312 | 568,707 | 440,646 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Revenues | 771,315 | 669,765 | 598,112 | 540,798 | ||
| Cost of revenue (Cost of Product and Service Sold) | (344,481) | (304,541) | (257,050) | (223,049) | ||
| Gross profit: | 426,834 | 365,224 | 341,062 | 317,749 | ||
| Operating expenses | (456,946) | (437,220) | (452,265) | (461,410) | ||
| Operating loss: | (30,112) | (71,996) | (111,203) | (143,661) | ||
| Nonoperating income (expense) | 10,597 | 9,232 | 1,307 | (347) | ||
| Income (loss) from continuing operations before income taxes: | (19,515) | (62,764) | (109,896) | (144,008) | ||
| Income tax expense | (875) | (433) | (497) | (263) | ||
| Income (loss) from continuing operations: | (20,390) | (63,197) | (110,393) | (144,271) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (144,271) | |
| Net income (loss) attributable to parent: | (20,390) | (63,197) | (110,393) | (144,271) | ||
| Preferred stock dividends and other adjustments | (13,137) | |||||
| Net income (loss) available to common stockholders, diluted: | (20,390) | (63,197) | (110,393) | (157,408) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (20,390) | (63,197) | (110,393) | (144,271) | ||
| Comprehensive income (loss): | (20,390) | (63,197) | (110,393) | (144,271) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (409) | (882) | (663) | (93) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (20,799) | (64,079) | (111,056) | (144,364) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.